Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,759,147
  • Shares Outstanding, K 75,469
  • Annual Sales, $ 0 K
  • Annual Income, $ -182,390 K
  • 60-Month Beta 1.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.31
Trade XENE with:

Options Overview Details

View History
  • Implied Volatility 53.13% ( -1.64%)
  • Historical Volatility 27.49%
  • IV Percentile 32%
  • IV Rank 16.10%
  • IV High 142.33% on 11/24/23
  • IV Low 36.02% on 06/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 94
  • Volume Avg (30-Day) 131
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 3,843
  • Open Int (30-Day) 3,814

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.72
  • Number of Estimates 7
  • High Estimate -0.63
  • Low Estimate -0.82
  • Prior Year -0.72
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.53 +1.66%
on 06/26/24
39.55 -8.67%
on 07/01/24
-2.32 (-6.04%)
since 06/03/24
3-Month
35.53 +1.66%
on 06/26/24
44.37 -18.59%
on 05/06/24
-5.18 (-12.54%)
since 04/03/24
52-Week
27.99 +29.07%
on 11/13/23
50.99 -29.16%
on 03/01/24
-2.13 (-5.57%)
since 07/03/23

Most Recent Stories

More News
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 36.12 (-1.20%)
Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023

Stocks that traded heavily or had substantial price changes on Monday: Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise

CRNC : 2.99 (-3.86%)
SHOP.TO : 91.84 (+1.67%)
NEM : 43.45 (+4.17%)
XENE : 36.12 (-1.20%)
FCX : 50.65 (+3.98%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Pharmaceuticals: Q2 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals: Q4 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Pharmaceuticals: Q3 Earnings Snapshot

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Xenon remains on track to initiate the XEN1101 Phase 3 program within second half of this year Cash runway extended into 2026 following successful...

XENE : 36.12 (-1.20%)
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update

BURNABY, British Columbia, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 36.12 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan...

See More

Key Turning Points

3rd Resistance Point 38.12
2nd Resistance Point 37.57
1st Resistance Point 36.84
Last Price 36.12
1st Support Level 35.56
2nd Support Level 35.01
3rd Support Level 34.28

See More

52-Week High 50.99
Fibonacci 61.8% 42.20
Fibonacci 50% 39.49
Fibonacci 38.2% 36.77
Last Price 36.12
52-Week Low 27.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar